Cadila Pharmaceuticals launches Bilacad Dex Syrup
Bilacad Dex Syrup is a triple-action formula for comprehensive respiratory relief
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Category
Market
High costs and limited access threaten progress in HIV treatment despite new drug advances:…
GlobalData’s report reveals that unmet needs, including underfunding of prevention programs, poor mental health integration,…
Nontuberculous mycobacteria market to reach $4.6 billion in 7MM in 2033, forecasts GlobalData
Market expansion driven by novel pipeline drugs and rising diagnosed prevalence, but generic competition may limit uptake of…
Torrent Pharmaceuticals to acquire controlling stake in JB Pharma from KKR for ₹25,689 crore,…
Torrent to first acquire 46.39 per cent stake in JB Pharma and initiate open offer, aiming to integrate operations through merger…
Biopharma innovation meets market headwinds tempering optimism: GlobalData
GlobalData’s report captures a moment for the global biopharmaceutical sector, where the pace of innovation is clashing with a…
Access to diabetes care for children and young people: Pharma companies’ current actions and…
A recently released report from Access to Medicine Foundation highlights that children and young people living in low-and…
Pharma sector sees $6.96 billion in global deal activity in May 2025, led by GSK, Shionogi, and Eli…
M&A and venture capital deals in the global healthcare sector declined from the 12-month average, with three transactions…
India’s pharma startups raise $254.7 million in May 2025: Tracxn
Seed-stage deals dominate as funding surges over fivefold from April, led by PB Healthcare’s $156 million round
India’s pharma funding falls by over 90% YoY in April 2025
Total funding drops to $57.7 million across 14 rounds, with early-stage investments comprising over half the capital deployed
SeQuent–Viyash merger receives stock exchange approvals; NCLT filing underway
The merger will bring together two business verticals—Global Animal Health and an integrated API business
GlobalData forecasts ADC NSCLC market to reach $3.9 bn in 2032
GlobalData’s patient-based forecast highlights that ADCs will see significant sales in the NSCLC space by 2032, led by…
China’s biopharma commands $30 billion in oncology licensing deals, triples US output in 2024
Significant reforms in clinical development processes and regulatory reviews in China have led to faster drug approvals,…
Cadila Pharmaceuticals launches Empadon (Empagliflozin)
Clinical trials have consistently shown empagliflozin’s efficacy in reducing cardiovascular mortality, heart failure…
Quadria Capital closes oversubscribed $1 bn fund III to advance healthcare across Asia
This latest fundraise is around 60 per cent larger than the firm’s previous $600 million fund raised in 2020
Biocon Biologics, Yoshindo launch Ustekinumab biosimilar in Japan
Ustekinumab, a monoclonal antibody, is approved for the treatment of psoriasis vulgaris and psoriatic arthritis (PsA)
Cipla launches ZEMDRI (Plazomicin) in India, aims to tackle AMR
Plazomicin is a novel anti-microbial with demonstrated activity against multi-drug resistant (MDR) bacteria and clinical efficacy…
Barentz acquires Fengli, China, aims to strengthen market presence
The partnership would further enhance the service and commercial capabilities of Barentz in China while enabling Fengli Group to…
Tezepelumab’s trial results strengthen potential for biomarker-driven biologic therapies in COPD:…
GlobalData’s latest analysis reveals that tezepelumab, evaluated in the Phase IIa COURSE trial, achieved a 26 per cent reduction…
US drug pricing order – Implications for India’s pharma sector
Ravi Shah, Partner, Cyril Amarchand Mangaldas explains that while the policy is designed to cut costs for US patients, its effects…
Gene therapies drive growth of genomics market, says GlobalData
GlobalData’s latest report reveals that the market for genomic therapies is demonstrating significant growth, with sales projected…